首页|基于甲基化修饰逆转探讨参术白胡颗粒治疗胃癌作用机制

基于甲基化修饰逆转探讨参术白胡颗粒治疗胃癌作用机制

扫码查看
目的:预测并验证参术白胡颗粒甲基化调控位点,探讨其治疗胃癌的作用机制。方法:采用NSG裸鼠胃癌模型验证参术白胡颗粒(下称"参术")的抗肿瘤作用。通过TCMSP、DrugBank、UniProt及PubChem数据库检索参术中的有效化学成分和作用靶点,在GeneCards、MalaCards和GEO数据库中获取胃癌差异表达基因,利用Venny 2。1。0将两者取交集获得参术治疗胃癌的潜在靶点。在STRING 11。5数据库构建蛋白相互作用网络图,利用DAVID数据库进行GO功能分析和KEGG通路富集分析,并通过Cytoscape软件构建"药物-成分-靶标-疾病-通路"网络图,从而筛选出参术治疗胃癌的关键通路和核心靶点。通过AutoDockTools 1。1。2软件将有效成分和核心靶点进行分子对接验证,使用Pymol软件进行作图结果可视化。最后采用RT-qPCR、Western blot和免疫组化法验证靶基因。结果:给药12d后,治疗组模型鼠肿瘤体积和质量均显著小于对照组(P<0。05)。通过网络药理学筛选出药物有效成分42种,潜在靶基因664个,与71个胃癌差异基因交集后得到15个靶基因。GO和KEGG分析得到11条通路和两个甲基化修饰的主要基因——DNMT1和EZH2。研究发现治疗组肿瘤组织中DNMT1和EZH2表达显著下降(P<0。05)。分子对接发现药物中7个有效成分与DNMT1和EZH2有对接活性。结论:参术白胡颗粒中金合欢素、木犀草素、槲皮素等7种关键有效活性成分可作用于DNMT1和EZH2核心靶蛋白,逆转DNA/组蛋白甲基化修饰,发挥抑制胃癌生长的药理作用。
Mechanism of treating gastric cancer with Shenzhu Baihu Granules based upon a reversal of methylation modification
OBJECTIVE To predict and verify the methylation regulatory sites of Shenzhu Baihu Granules(Shenzhu)and explore its mechanism of action in treating gastric cancer(GC).METHODS Anti-tumor effect of Shenshu was verified by a NOD scid gamma(NSG)nude murine model of GC.The effective chemical components and surgical targets were mined by searching the databases of Traditional Chinese Medicine Systems Pharmacology Database & Analysis Platform(TCMSP),Drug-Bank,UniProt and PubChem and the differentially expressed genes of GC retrieved from the databases of GeneCards,MalaCards and GEO.The potential surgical targets for GC were obtained by intersection of both with Venny 2.1.0.A protein interaction network diagram was constructed in the database of STRING 11.5.GO functional and KEGG pathway enrichment analyses were performed with the database of DAVID.And a"drug component target disease pathway"network diagram was constructed with Cytoscape software for screening out key pathways and core targets for treating GC.Molecular docking verification of active ingre-dients and core targets was performed by AutoDockTools 1.1.2 software.And visualization of mapping results was enabled by Pymol software.Finally real-time quantitative polymerase cahin reaction(RT-qPCR),Western blot and immunohistochemistry were utilized for verifying target genes.RESULTS After 12-day dosing,tumor volume and weight of treatment group were sig-nificantly smaller than those of control group(P<0.05).A total of 42 effective drug ingredients were screened through network pharmacology with 664 potential target genes.After intersecting with 71 differentially expressed genes in GC,15 target genes were obtained.GO/KEGG analysis revealed 11 pathways and two major genes for methylation modification-DNMT1 and EZH2.There was a significant marked down-regulation of DNMT1/EZH2 in tumor tissue of treatment group(P<0.05).Molecular docking revealed that 7 active drug ingredients possessed docking activity with DNMT1/EZH2.CONCLUSION Seven key active ingredients in Shenshu,including acacia,luteolin and quercetin,may act on DNMT1/EZH2 core target proteins,reverse DNA/histone methylation modification and exert inhibitory effects on GC growth.

gastric cancerShenzhu Baihu GranulesDNMT1EZH2DNA methylationhistone modifications

刘盼盼、任伟宏、张旭冉、苗晋鑫、李文博、韩文彦、冯倩、冯慧洁、荣昊、贺娇、张振强

展开 >

河南中医药大学第一临床医学院,河南郑州 450046

河南中医药大学第一附属医院检验科,河南郑州 450000

胃癌 参术白胡颗粒 DNMT1 EZH2 DNA甲基化 组蛋白修饰

国家自然科学基金项目河南省科技攻关项目

82174146212102310639

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(7)
  • 23